Mar 4, 2022
101 Therapeutics
in the news
We have successfully completed Phase I clinical safety trials and have begun Phase II trials in acute COVID-19.
Research
Future
For more information, please visit
https://clinicaltrials.gov/ct2/show/NCT05195749
Home
Our Science
Pipeline
News
Careers
Contact Us